Effect of magnetic seizure therapy on regional brain glucose metabolism in major depression

Psychiatry Research - Neuroimaging

Volumn 211, Issue 2, 2013, Pages 169-175

  Hoy, Kate E ^a   Thomson, Richard H ^a   Cherk, Martin ^b   Yap, Kenneth S K ^b   Daskalakis, Zarifis J ^c   Fitzgerald, Paul B ^a  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antidepressant response; Depression; Neuromodulation; Positron emission tomography; Relative brain glucose metabolism; Treatment

Indexed keywords

ADULT; ANTERIOR CINGULATE; ARTICLE; BASAL GANGLION; BRAIN GLUCOSE METABOLISM; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; ELECTROENCEPHALOGRAM; FEMALE; FRONTAL CORTEX; GANGLION; GLOBUS PALLIDUS; GLUCOSE METABOLISM; HUMAN; LEFT HEMISPHERE; MAGNETIC SEIZURE THERAPY; MAGNETOTHERAPY; MAJOR DEPRESSION; MALE; ORBITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; SECONDARY ANALYSIS; SEIZURE THRESHOLD; TONIC CLONIC SEIZURE; TREATMENT RESISTANT DEPRESSION; TREATMENT RESPONSE;

ADULT; BRAIN; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; FEMALE; FUNCTIONAL NEUROIMAGING; GLUCOSE; HUMANS; MAGNETIC FIELD THERAPY; MALE; MIDDLE AGED; PILOT PROJECTS;

EID: 84873470053     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2012.08.003     Document Type: Article

References (36)

1. Damasio A.R., Eslinger P.J., Damasion H., Van Hoesen G.W., Cornell S. Multimodal amnesic syndrome following bilateral temporal and basal forebrain damage. Archives of Neurology 1985, 42:252-259.
2. Drevets W.C. Functional neuroimaging studies of depression: the anatomy of melancholia. Annual Review Medicine 1998, 49:341-361.
3. Dwork A.J., Arango V., Underwood M., et al. Absence of histological lesions in primate models of ECT and magnetic seizure therapy. American Journal of Psychiatry 2004, 161:576-578.
4. Fava M. Diagnosis and definition of treatment-resistant depression. Biological Psychiatry 2003, 53:649-659.
5. Fitzgerald P.B., Laird A.R., Maller J, Daskalakis Z.J. A meta-analytic study of changes in brain activation in depression. Human Brain Mapping 2008, 29:683-695.
6. Goldapple K., Segal Z., Garson C., et al. Modulation of cortical-limbic pathways in major depression. Archives of General Psychiatry 2004, 61:34-41.
7. Hoy K.E., Fitzgerald P.B. Brain stimulation in psychiatry and its effects on cognition. Nature Reviews Neurology 2010, 6:267-274.
8. Hoy K.E., Fitzgerald P.B. Magnetic seizure therapy for treatment-resistant depression. Expert Review of Medical Devices 2011, 8(6):723-732.
9. Ingram A., Saling M.M., Schweitzer I. Cognitive side effects of brief pulse electroconvulsive therapy: a review. Journal of ECT 2008, 24:3-9.
10. Kayser S., Bewernick B., Grubert C., Hadrysiewicz B.L., Axmacher N., Schläpfer, T.E., 2011. Antidepressant effects of magnetic seizure therapy and electroconvulsive therapy in treatment-resistant depression. Journal of Psychiatric Research 45 (5), 569-576.
11. Kayser S., Bewernick B., Schläpfer T.E. Magnetic seizure therapy (MST) of 10 depressive patients. Brain Stimulation 2008, 1:229-237.
12. Kennedy S.H., Konarski J.Z., Segal Z.V., et al. Differences in brain glucose metabolism between responders and non responders to CBT and venlafaxine in a 16 week randmoised controlled trial. American Journal of Psychiatry 2001, 164:778-788.
13. Kirov G., Ebmeier K.P., Scott A.I., et al. Quick recovery of orientation after magnetic seizure therapy for major depressive disorder. British Journal of Psychiatry 2008, 193:152-155.
14. Kopelman M.D. Frontal dysfunction and memory deficits in the alcoholic Korsakoff syndrome and Alzheimer-type dementia. Brain 1991, 114:117-137.
15. Kosel M., Frick C., Lisanby S.H., Fisch H.U., Sackeim H.A., Schlaepfer T. Magnetic seizure therapy improves mood in refractory major depression. Neuropsychopharmacology 2003, 28:2045-2048.
16. Lisanby S.H., Luber B., Finck A.D., Sackeim H.A. Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates. Archives of General Psychiatry 2001, 58:199-200.
17. Lisanby S.H., Luber B., Schlaepfer T.E., Sackeim H.A. Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology 2003, 28:1852-1865.
18. Lisanby S.H., Schlaepfer T., Fisch H.U., Sackeim H.A. Magnetic seizure therapy of major depression. Archives of General Psychiatry 2001, 58:303-305.
19. Mayberg H.S., Brannan S.K., Tekell J.L., Silva J.A., Mahurin R.K., McGinnis S., Jerabek P.A. Regional metabolic effects of fluxoetine in major depression: serial changes in and relationship to clinical response. Biological Psychiatry 2000, 48:830-843.
20. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., Silva J.A., Tekell J.L., Martin C.C., Lancaster J.L., Fox P.T. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. American Journal of Psychiatry 1999, 156:675-682.
21. Mayberg H.S. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain based algorithms for diagnosis and optimzed treatment. British Medical Bulletin 2003, 65:193-207.
22. Mayberg H.S. Targeted electrode-based modulation of neural circuits for depression. Journal of Clinical Investigation 2009, 119(4):717-725.
23. Montgomery S.A., Åsberg M.A. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979, 134:382-389.
24. Moscrip T.D., Terrace H.S., Sackeim H.A., Lisanby S.H. Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS). International Journal of Neuropsychopharmacolgy 2006, 9(1):1-11.
25. Nobler M.S., Oquendo M.A., Kegeles L.S., et al. Decreased regional brain metabolism after ECT. American Journal of Psychiatry 2001, 158:305-308.
26. Payne N.A., Prudic J. Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT. Journal of Psychiatry Practice 2009, 15:346-368.
27. Sackeim H.A., Luber B., Moeller J.R., Prudic J., Devanand D.P., Nobler M.S. Electrophysiological correlates of the adverse cognitive effects of electroconvulsive therapy. Journal of ECT 2000, 16(2):110-120.
28. Sackeim H.A., Prudic J., Fuller R., Keilp J., Lavori P.W., Olfson M. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology 2007, 32:244-254.
29. Sackeim H.A. Memory and ECT: from polarisation to reconciliation. Journal of ECT 2000, 16(2):87-96.
30. Schmidt E.Z., Reininghaus B., Enzinger C, Ebner C., Hofmann P., Kapfhammer H.P. Changes in brain metabolism after ECT - positron emission tomography in the assessment of changes in glucose metabolism subsequent to electroconvulsive therapy - lessons, limitations and future applications. Journal of Affective Disorders 2008, 106(1):203-208.
31. Shimamura A.P. Memory and frontal lobe function. The Cognitive Neurosciences 1994, 803-813. MIT Press, Cambridge, MA. M.S. Gazzaniga (Ed.).
32. Sienaert P., Becker De, Vanstellandt K., Demyttenaere K., Peuskens J. Patient satisfaction after electroconvulsive therapy. Journal of ECT 2005, 21(4):227-231.
33. Speer A.M., Kimbrell T.A., Wassermann E.M., et al. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biological Psychiatry 2000, 48:1133-1141.
34. Spellman T., McClintock S.M., Terrace H., Luber B., Husain M.M., Lisanby S.H. Differential effects of high-dose magnetic seizure therapy and electroconvulsive shock on cognitive function. Biological Psychiatry 2008, 63:1163-1170.
35. Teneback C.C., Nahas Z., Speer A.M., Molloy M., Stallings L.E., Spicer K.M., Risch S.C., George M.S. Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS. Neuropsychiatry and Clinical Neuroscience 1999, 11:426-435.
36. White P.F., Amos Q., Zhang Y., Stool L., Husain M.M., Thornton L., Downing M., McClintock S., Lisanby S.H. Anaesthetic considerations for magnetic seizure therapy: a novel therapy for severe depression. Anesthetics and Analgesia 2006, 103:76-80.